Unlock instant, AI-driven research and patent intelligence for your innovation.
Drug for treating hepatitis B
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A drug, hepatitis B technology, applied in the field of pure traditional Chinese medicine composition for the treatment of hepatitis B, can solve the problems of immune dysfunction, treatment failure, complex disease, etc., and achieve the effect of short course of treatment, quick effect, and promotion of curative effect
Inactive Publication Date: 2010-06-23
张淑芬
View PDF2 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
During the course of treatment, the patient's condition often fluctuates and occurs repeatedly. In addition, the immune function of chronic hepatitis B patients is dysfunctional, and "mixed infections" may occur during treatment, such as hepatitis B + hepatitis C, hepatitis B + hepatitis D, hepatitis B + hepatitis A, etc., or hepatitis B Combined with fatty liver, sometimes due to abuse of drugs, drinking, etc., making the condition complicated and more difficult to treat
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
A drug for treating hepatitis B is characterized by being made from the mixture of bupleurum, gardenia, radix scutellariae, isatis root, salvia miltiorrhiza, herba artemisiae capillaris, rhubarb, rhizoma coptidis, cyperus rotundus, desmodium, rhizoma sparganii, endothelium corneum gigeriae galli, Chinese angelica, dried rhizome of rehmannia, radix aucklandiae, dried tangerine peel, sealwort, malt,hawthorn, medicated leaven, semen plantaginis, poria, turtle shell, date and gentian. The drug has simple process, the effects of adjusting immunologic function, inducing the occurrence of interferon, inhibiting and eliminating hepatitis B virus, promoting hepatocyte repair, improving liver microcirculation and promoting the reliable treating effect of hepatitis B antigen negative conversion, short treating period, fast effect, no relapse after cure and low cost. The drug is handed down from the ancestor over 200 years before and cures tens of thousands of patients with the effective rate upto 100 percent.
Description
technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a pure traditional Chinese medicinal composition for treating hepatitis B. Background technique [0002] HBV infection is the most common viral disease, affecting approximately 300 million people worldwide. So far, there is only one drug approved for the treatment of hepatitis B—interferon. In addition to causing influenza-like syndrome, the application of interferon can also cause leukopenia, thrombocytopenia, hair loss, depression, etc., sometimes because of toxic side effects. Frustrated, and its price is also relatively expensive. Lamivudine is the first nucleoside drug approved for the treatment of hepatitis B. However, the incidence of drug resistance during treatment is as high as 49%. Most patients rebound after drug withdrawal, and a few cases even lead to severe illness hepatitis. Another problem that anti-HBV drugs exist is that the patient's "response rate" is not ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More